Prostate Cancer - Results from #25780

AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD May 30, 2012

Management of patients with metastatic prostate cancer - Abstract May 29, 2012

Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort - Abstract May 29, 2012

Active surveillance for favorable-risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes - Abstract May 29, 2012

EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy - Abstract May 29, 2012

Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations - Abstract May 29, 2012

Androgen deprivation therapy in prostate cancer. Indication and systemic consequences - Abstract May 29, 2012

Patterns of prostate-specific antigen (PSA) testing in Australian men: The influence of family history - Abstract May 29, 2012

Cancer overdiagnosis and overtreatment - Abstract May 29, 2012

The role of 5-alpha-reductase inhibitors in active surveillance - Abstract May 29, 2012

Prostate cancer epidemiology in the United States - Abstract May 29, 2012

Q Fever masquerading as prostate cancer metastases - Abstract May 28, 2012

Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings - Abstract May 28, 2012

Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer - Abstract May 28, 2012

Health economics evaluation of magnetic resonance imaging for the staging of prostate cancer for Austria and Germany - Abstract May 28, 2012

Novel agents for the management of castration-resistant prostate cancer - Abstract May 28, 2012

Overcoming castration resistance in prostate cancer - Abstract May 28, 2012

Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer - Abstract May 28, 2012

Prostate-specific antigen levels in men aged 70 years and over: Findings from the CHAMP study - Abstract May 28, 2012

Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia - Abstract May 28, 2012

Page 1290 of 1437